Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ADH1B | P00325 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23773261 | 1.00 | KMT2A (0.41) | KMT2AADH1BADH1CADH1AANPEP | |
| SCHEMBL14839102 | 0.79 | KMT2A (0.38) | KMT2A | |
| SCHEMBL3966902 | 0.76 | KMT2A (0.33) | KMT2AADH1BADH1CADH1A | |
| SCHEMBL12477914 | 0.75 | KMT2A (0.36) | KMT2A | |
| SCHEMBL12478501 | 0.75 | — | — | |
| SCHEMBL7114276 | 0.74 | ALDH1A1 (0.30) | — | |
| SCHEMBL7120937 | 0.74 | TSHR (0.40) | ANPEP | |
| Hydrochloric Acid SCHEMBL6123301 | 0.74 | KMT2A (0.32) | KMT2A | |
| SCHEMBL27552233 | 0.74 | TSHR (0.40) | ANPEP | |
| SCHEMBL94675 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10934295-B2 | Antimicrobials and methods of making and using same | BioVersys AG (CH) | 2021-03-02 | — | — | US | disclosed |
| US-20190211018-A1 | ANTIMICROBIALS AND METHODS OF MAKING AND USING SAME | RIB-X PHARMACEUTICALS, INC. | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10934295-B2 | Antimicrobials and methods of making and using same | LPO, MPO, OAT | KMT2A 4640/4885ADH1B 1402/4885ADH1C 3856/4885 |
| US-20190211018-A1 | ANTIMICROBIALS AND METHODS OF MAKING AND USING SAME | LPO, MPO, OAT | KMT2A 4640/4885ADH1B 1402/4885ADH1C 3856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.